CurrentCardio
Get Weekly

CurrentCardio coverage · page 2 of 8

JACC: Heart Failure

Briefs 41–80 of 317 CurrentCardio has covered from this journal, newest publication first

Latest from JACC: Heart Failure

All coverage, newest first

  1. JACC Heart Fail

    10-Year Survival and Renal Outcomes After Simultaneous Heart-Kidney Transplantation in Heart Retransplant Recipients

    Cohort studyHeart failure

  2. JACC Heart Fail

    Cost-Effectiveness of Tirzepatide for the Management of Heart Failure With Preserved Ejection Fraction and Obesity

    Research articleHeart failure

  3. JACC Heart Fail

    Excess and Dysfunctional Fat as a Primary Driver of Heart Failure With Preserved Ejection Fraction: From Institutional Recognition to Clinical Integration

    Research articleHeart failure

  4. JACC Heart Fail

    Screening Strategies for Identification of Transthyretin Amyloid Cardiomyopathy

    Research articleHeart failure

  5. JACC Heart Fail

    Diuretic Resistance Risk and the Efficacy of Natriuresis-Guided Diuretic Therapy in Acute Heart Failure: Post Hoc Analysis From the PUSH-AHF Trial

    Secondary analysisHeart failure

  6. JACC Heart Fail

    Socioeconomic Correlates of Incident Heart Failure and Consequent Mortality: The All of Us Program

    Cohort studyHeart failure

  7. JACC Heart Fail

    Secondary Mitral Regurgitation Trajectories and Prognosis With Intensification of Guideline-Directed Medical Therapy in Heart Failure

    Cohort studyHeart failure

  8. JACC Heart Fail

    Empagliflozin in De Novo vs Acute Decompensated Chronic Heart Failure: A Prespecified Analysis From EMPULSE

    Secondary analysisHeart failure

  9. JACC Heart Fail

    Kidney Disease and Heart Failure: Recent Advances and Current Challenges: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Guideline or statementHeart failure

  10. JACC Heart Fail

    Physician-Directed Patient Self-Management Using an Implantable IVC Congestion Sensor: Insights From FUTURE-HFII

    Cohort studyHeart failure

  11. JACC Heart Fail

    Seated Pulmonary Artery Pressure Management in Patients With Heart Failure: 12-Month Outcomes of the PROACTIVE-HF Trial

    Research articleHeart failure

  12. JACC Heart Fail

    Progression From Exercise-Induced to Resting Left Atrial Hypertension in HFpEF: Impact of Reduced Atriopulmonary Compliance

    Cohort studyHeart failure

  13. JACC Heart Fail

    Left Atrial Volumetric Enlargement in Heart Failure With Reduced Ejection Fraction: Obligatory Consequence or Independent Predictor of Outcome?

    Cohort studyHeart failure

  14. JACC Heart Fail

    Heart Replacement Therapy in Young Patients: A Comparative Analysis of HeartMate 3 LVAD and Heart Transplant Using MOMENTUM 3 and UNOS Registry

    Cohort studyHeart failure

  15. JACC Heart Fail

    Standardized Reporting in Heart Failure Noninvasive Remote Monitoring Trials: Interventions to Catalyze Data Into Action

    Guideline or statementHeart failure

  16. JACC Heart Fail

    Lactate Dehydrogenase and Outcomes in Patients With HF and Reduced Ejection Fraction: Insights From GALACTIC-HF

    Secondary analysisHeart failure

  17. JACC Heart Fail

    Implications of Potential Undiagnosed HFpEF on Symptomatic Response With Coronary Revascularization

    Secondary analysisHeart failure

  18. JACC Heart Fail

    Early Diagnosis of ATTR-CM Using Carpal Tunnel Biopsy Examination: EDUCATE: A United Kingdom Prospective Multicenter Study

    Cross-sectional studyHeart failure

  19. JACC Heart Fail

    Serum Magnesium, Outcomes, and the Effect of Empagliflozin in Heart Failure With Mildly Reduced and Preserved Ejection Fraction: Findings From EMPEROR-Preserved

    Secondary analysisHeart failure

  20. JACC Heart Fail

    Severe Myocarditis Increase in Children Associated With Parvovirus B19 Infection: MYKKE Registry and German Surveillance Data

    Cohort studyHeart failure

  21. JACC Heart Fail

    Mechanically Reducing Cardiac Preload With the preCARDIA System in Acutely Decompensated Heart Failure

    Cohort studyHeart failure

  22. JACC Heart Fail

    National Trends and Disparities in Heart Failure Hospitalizations and Inpatient Outcomes Between 2010-2022

    Cohort studyHeart failure

  23. JACC Heart Fail

    Monitoring Disease Progression in Patients With Transthyretin Amyloid Cardiomyopathy

    Guideline or statementHeart failure

  24. JACC Heart Fail

    Rising Exception Requests in the Current Heart Allocation System

    Cohort studyHeart failure

  25. JACC Heart Fail

    Heart Failure With Preserved Ejection Fraction Across the Spectrum of Body Mass Index: Hemodynamic and Echocardiographic Characteristics and Outcomes

    Cohort studyHeart failure

  26. JACC Heart Fail

    Hemocompatibility Outcomes With Pharmacological Therapy Following LVAD Implantation: Insights From the ARIES-HM3 Trial

    Secondary analysisHeart failure

  27. JACC Heart Fail

    Phase I Randomized Study of Cardiac Stem Cells in Patients With Hypoplastic Left Heart Syndrome: The CHILD Trial

    Randomised controlled trialCongenital

  28. JACC Heart Fail

    Cardiac Biomarkers, Intensive Lifestyle Intervention, and Heart Failure Subtypes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary Study

    Secondary analysisHeart failure

  29. JACC Heart Fail

    Serum Magnesium and the Effect of Empagliflozin in Heart Failure With Reduced Ejection Fraction: Findings From EMPEROR-Reduced

    Secondary analysisHeart failure

  30. JACC Heart Fail

    A Novel Computational Pipeline for Acquiring Pressure-Volume Hemodynamics of the Right Ventricle in Pulmonary Hypertension

    Diagnostic or prognostic studyPulmonary vascular & VTE

  31. JACC Heart Fail

    Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CRD-740, a PDE9 Inhibitor, in Chronic Heart Failure

    Randomised controlled trialHeart failure

  32. JACC Heart Fail

    Diet and Clinical Outcomes in a Heart Failure Population

    Cohort studyHeart failure

  33. JACC Heart Fail

    Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection: An Analysis of the Surveillance HeartCare Outcomes Registry

    Cohort studyHeart failure

  34. JACC Heart Fail

    Efficacy and Safety of Omecamtiv Mecarbil in Heart Failure With Reduced Ejection Fraction According to Age: The GALACTIC-HF Trial

    Secondary analysisHeart failure

  35. JACC Heart Fail

    Cardiovascular-Kidney-Metabolic Disease Burden in Children and Adults Following Heart Transplantation

    Cohort studyHeart failure

  36. JACC Heart Fail

    Prevalence and Associations of Systemic Inflammation in Heart Failure Across the Spectrum of Ejection Fraction

    Meta-analysisHeart failure

  37. JACC Heart Fail

    Primary Graft Dysfunction in Patients Supported With Durable Left Ventricular Assist Devices Before Heart Transplantation

    Cohort studyHeart failure

  38. JACC Heart Fail

    Long-Term Outcomes in Women With a History of Peripartum Cardiomyopathy

    Cohort studyHeart failure

  39. JACC Heart Fail

    Impact of Preoperative Temporary Mechanical Circulatory Support on Durable LVAD Outcomes: An Analysis of The Society of Thoracic Surgeons National Intermacs Database

    Cohort study

  40. JACC Heart Fail

    Iron Deficiency Definitions in Heart Failure Across Ejection Fraction Phenotypes: Prevalence, Symptoms, and Cause-Specific Outcomes

    Cohort studyHeart failure

All 317 Briefs in ExploreShowing Briefs 41–80 of 317, newest first